Table 1 Descriptive statistics of clinical trial, placebo arm MS patients derived from the open data set of the SLCMSR and included in "Individual Risk Profile" OLAP-tool, version 2.0.0, divided by the four different courses CIS clinically isolated syndrome, RR relapsing remitting, SP secondary progressive and PP primary progressive.
| Â | Disease subtype | |||
|---|---|---|---|---|
Database patient characteristics | CIS | RR | SP | PP |
No. of patients | 124 | 460 | 455 | 20 |
Sex ratio (m/f) | 0.38 | 0.41 | 0.69 | 0.82 |
Age at onset (Median and 5%- and 95%- percentile) | 30 [19;40] | 29 [17;41] | 29 [18;45] | 37 [19;57] |
Baseline EDSS (Median and 5%- and 95%- percentile) | 1.5 [0.0;5.0] | 2.5 [1.0;5.5] | 5.5 [3.0;6.5] | 3.5 [1.5;6.0] |
Duration (months) (Median and 5%- and 95%- percentile) | 2 [0;104] | 66 [7;225] | 148 [40;341] | 50 [11;190] |
Relapses last 12 months: no relapse | 5 | 47 | 256 | 6 |
Relapses last 12 months: 1 relapse | 115 | 131 | 97 | 4 |
Relapses last 12 months: 2 or more relapses | 0 | 132 | 36 | 1 |
Relapses last 12 months: unknown | 4 | 150 | 66 | 9 |